2nd International Conference on

Dementia and Dementia Care

Toronto, Canada   April 15 -16, 2019

Dementia 2019

Theme: Breakthrough in Dementia Research and Care

With the amalgamation of peerless speakers of Dementia 2018 we are privileged to announce its “2nd International Conference on Dementia and Dementia Care” which is going to be held on April 15-16, 2019 at Toronto, Canada. The theme of the conference is “Breakthrough in Dementia Research and Care” which reflects the innovative progress in Dementia research. We cordially welcome all the eminent researchers, students and delegates to take part in this upcoming Dementia Conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Dementia & Dementia Care. Dementia 2019 Conference will focus on the latest and exciting innovations in the area of Dementia research and care which offers a unique opportunity for investigators across the globe to meet, network, perceive new scientific innovations and explore creative ways to improve the quality of life and support of people, of all ages, living with all forms of dementia. 

The two days Dementia Conference includes workshops, symposiums, special keynote sessions conducted by eminent and renowned speakers who excel in the field of Dementia and Dementia Care. The sessions include wide range of topics like Dementia, Dementia Care & Awareness, Alzheimer’s disease, diagnostic Tools & Tests for Dementia, Treatment Strategies, Drug Discovery, Clinical Trials & Study in Dementia, Biomarkers for Dementia, Animal Models for Dementia Research, Vaccine for Dementia, Recent Studies & Case reports.

The aim of Dementia Conference 2019 is to give a platform for researchers to explore and learn the latest research. Present before distinguished global audience. Collaborate, build partnerships and experience Canada (Toronto). Neuroscientist, neurological surgeon, neuro drug manufacturers, students, delegates and officials from various fields of neuroscience are invited to take part in the mind opening sessions, gathering and presentations at this esteemed Dementia Care Conference.

Meetings International (Meetings Int.) is the world’s leading specialist in organizing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. It has been associated with national and international associations, corporations and high level individuals, dedicated to host world class conferences and events. The main objective of Meetings Int. is to correlate science and medical research between academia, and industry. Through inspiring sessions and networking, you will learn to be even more audacious and bold than you are now and free to grow your mind, grow your business, and grow your bottom-line.

Why Toronto for Dementia Care Conference 2019?

Toronto is the major and the capital city of the province of Ontario in Canada. It is the largest population centre in Ontario by population over 5 million. It is situated on the north-west shore of Lake Ontario. Toronto’s motto is “Diversity Our Strength. This city is a global finance, commerce as well as transportation hub. It has always been ranked highly in the fields of life expectancy, personal safety, healthcare, education etc.

The proportion of Canadians living with Alzheimer disease and related dementias is rising day by day. Using rates drawn from the Canadian Study on Health and Aging, it was estimated that in 2016 there were 564,000 persons in Canada living with dementia. By 2031 it is estimated that the number will increase to 937,000 (see Table) of which the percentage for women will be 65 percent.

Hence, we need to think upon it and need to tackle this growing problem. So we are organizing this time in Toronto, Canada in order to emphasize on dementia treatment, prevention and most importantly dementia care so that persons with dementia can seek medical attention early. We hope you will join us at Dementia Conference 2019 and make this event fruitful.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England.

Session 1: Dementia

Dementia is now the leading cause of death that has caused more deaths than heart disease. It is a group of symptoms that leads to brain function decline and memory impairment.

It can be grouped based on the part of brain being affected. A dementia results in a change from a person's usual mental functioning and a greater decline than one would expect due to aging. Alzheimer's and Creutzfeldt-Jakob disease are two forms of cortical dementia. Parkinson's disease, Huntington's disease, and HIV are two forms subcortical dementia.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia SymposiumMedical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of America, Alzheimer's Family Support Group, Dementia Research Foundation, Dementia Alliance International, Society for Neuroscience Washington, DC, Albanian Alzheimer Society, Alzheimer Society of Bangladesh, World Dementia Council, Alzheimer’s Disease Foundation Malaysia, Alzheimer’s Disease Association Singapore, Alzheimer’s Disease and Related Disorders Association Thailand, The British Neuroscience Association, England

Session 2: Dementia Care & Awareness

Caring of person with dementia is a difficult task both for families and caregivers. Individual with dementia have progressive brain disorder and memory loss, which makes them difficult to do daily activities. They need support and care.

Most persons with dementia die of acute illness and many are hospitalised at the end of life. In the acute hospital setting, limitation of care orders (LCOs) such as Do Not Attempt CPR and Physician Orders for Life Sustaining Treatment (POLST), appear to be underused in patients with dementia.  These patients receive the same aggressive life-prolonging therapies as any other patient, despite drastically higher mortality.

Caring for people with dementia is a vital and rewarding service. Caring with dignity and respect allows the affected person to retain as much of who they were as possible and removing much of the fear for both the individual and their family. The right care can limit the negative impact of the unpredictability of dementia. Several associations are there which are often helpful in completing these tasks.

  • Dementia Nursing
  • Psychiatric / Mental status Evaluation
  • Dementia Care & Consulting
  • Society & Culture

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 3: Alzheimer’s disease

Alzheimer's is a chronic neurodegenerative disease. It is the most common form of dementia and accounts for 60 to 80% of dementia cases. It causes problems with memory, thinking and behaviour. Symptoms usually develop slowly and get worse over time, gradually become severe enough to interfere with day to day work. People with Alzheimer's live an average life of eight years after the symptoms become visible. There is no current cure for Alzheimer's, but treatments for symptoms are available and the research is continued.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 4: Neurodegenerative Diseases

Neurodegenerative diseases consist of wide range of disorders, characterized by the progressive degeneration or death of nerve cells. It affects nerve tissue and causes different neuropsychological manifestations as well. It is an umbrella term for a range of conditions which particularly affect the neurons in the human brain.

Genetic and environmental factors have been shown to play a vital role in the development of neurodegenerative diseases. Age is one of the major risk factor that is common between all types of neurodegenerative disease as it progresses at older ages commonly.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 5: Ageing & Dementia

Recent data show that as population’s age, the number of people affected by neurodegenerative dementia is growing at an epidemic pace in various regions of the world. 

Around 40 per cent of people over the age of 65 experience some form of memory loss. This kind of memory loss is "age-associated memory impairment," which is considered a part of the normal aging process. But memory loss in Alzheimer’s disease and other dementias are different.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 6: Biomarkers for Dementia

Dementia represents a burgeoning public health problem that already causes untold suffering and threatens to overwhelm health care delivery systems in the coming decades.

One reaction to the approaching pandemic of twisting sickness is the advancement of biomarkers that can help in determination, forecast, choice for clinical trials, and target evaluation of remedial reaction. Imaging, cerebrospinal fluid (CSF) and blood-based biomarkers have the potential to improve the accuracy by which specific causes of dementia can be diagnosed in vivo, but more research is required to improve the efficacy.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 7: Diagnostic Tools & Tests for Dementia

There is no one test to identify if someone has dementia. Doctors diagnose dementia based on a careful medical history, a physical examination, laboratory tests, and the characteristic changes in thinking, day-to-day activities and behaviour associated with each type.

It is difficult to determine the exact type of dementia because the symptoms are very similar and brain changes of different dementias can overlap.

Diagnosis can be aided by:

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 8: Treatment Strategies & Drug Development            

Treatment of dementia depends on its cause. In most of the cases there is no cure and no treatment that slows or stops its progression. Memory treatment has a great impact on dementia patients. It utilizes past frequencies and urge patients to compose and clarify past rates which help in keeping up psychological wellness. Physical exercise has shown some benefits in helping to maintain cognition. Staying engaged and participating in social events may also be helpful.

But there are drug treatments that may temporarily improve symptoms. Ultimately, the path to effective new treatments for dementia is through increased research funding and increased participation in clinical studies & drug development.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 9: Therapeutic Approach towards Dementia

There are numerous ways to categories interventions in dementia care, for instance, by the kind of treatment approach used.  The chief grouping is by the therapeutic goal, with three considerable spheres recommended: the maintenance of function, including cognitive functions, the management of behaviours that challenge and the reduction of comorbid emotional disorders.

The range of non-pharmacological ‘interventions’ in dementia care is ample and would include the everyday interactions of cares with the person suffering from dementia, the effect of the physical and social conditions and all manner of  ‘therapies’, ranging from art sessions to contact with animals.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 10: Clinical Trials & Study in Dementia

There are two types of Alzheimer's treatment trials:

  • One aimed at reducing symptoms. During this type of trial, new medicines and variations of existing medicine that reduce the symptoms of Alzheimer's disease are tested.
  • Second aimed at slowing or terminating the disease. During this type of trial, new drugs designed to slow or stop Alzheimer's are tested.

Scientists are making great efforts in identifying potential new ways to help diagnose, treat, and even prevent Alzheimer’s and related dementias. Without clinical trials, there can be no better treatments, no prevention and no cure for neurological disease.

  • Vaccine for Dementia
  • Treatment trials
  • Diagnostic studies
  • Prevention trials
  • Quality of life studies

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 11: Neuroimaging

Although detailed clinical appraisal frames the premise of assessing a patient with psychological disability, structural and functional imaging techniques are logically being used. Neuroimaging can recognize changes to supplement the clinical analysis and help to recognize dementia subtypes. This might be critical for treatment, prognosis and care planning.

New imaging strategies convey the expectation of revolutionizing the diagnosis of neurodegenerative disease to acquire an entire molecular, structural, and metabolic characterization, which could be used to improve diagnosis and to stage each patient and follow disease progression and response to treatment.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

Session 12: Recent Studies & Case reports

Dementia is a progressive, irreversible decline in cognition that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementia has several etiologies of which Alzheimer’s disease (AD) is the most common.

Drug development in AD is based on evolving pathophysiological theory. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signalling, neuro-inflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and ongoing promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.

Dementia Conference | Dementia Care Conference | Dementia Conferences | Dementia 2019 | Alzheimer’s disease Conference | Neuroscience Workshop | Dementia Meeting | Neurological Disorder Congress | Dementia Symposium | Medical Conference | Dementia Forum | Neurodegenerative Disease Congress | Brain Disease Event | Dementia Canada | Toronto Event

Related Associations and Societies: Dementia Society of AmericaAlzheimer's Family Support GroupDementia Research FoundationDementia Alliance InternationalSociety for Neuroscience Washington, DCAlbanian Alzheimer SocietyAlzheimer Society of BangladeshWorld Dementia CouncilAlzheimer’s Disease Foundation MalaysiaAlzheimer’s Disease Association SingaporeAlzheimer’s Disease and Related Disorders Association ThailandThe British Neuroscience Association, England

 

Dementia is a progressive, irreversible decline in cognition that, by definition, impacts on a patient pre-existing level of functioning. It is now the leading cause of death that has caused more deaths than heart disease. This conference on Dementia and Dementia Care will gather researchers from all over the world, where they can exchange their knowledge and share ideas.

Global Statistics

Worldwide, around 50 million people have dementia. The numbers of people living with dementia in low income countries will increase by 264%, between 2015 and 2050, and by 227% in upper middle income countries, by 223% in lower middle income countries and by 116% in high income countries.

The estimated proportion of the general population aged 60 and over with dementia at a given time is between 5- 8 per 100 people. The total number of people with dementia is projected to near 75 million in 2030 and almost triple by 2050 to 132 million.

Global Business & Research Value

Dementia has significant social and economic implications in terms of direct medical costs, direct social costs, and the costs of informal care.

The worldwide costs of dementia were estimated is $818 billion in 2015, an increase of 35% since 2010. Costs of informal care and the direct costs of social care still contribute similar proportions of total costs, whereas the costs in the medical sector are much lower. The threshold of US $1 trillion will be crossed by 2018.

Only about a third of the population is receiving the therapy or medication needed, mental illnesses cause a huge economic and social burden, it is found that the cost burden of these and other neurological disorders amounted to about 386 billion euros ($555 billion) a year. An estimated 6.8 million people die every year as a result of neurological disorders.

This industry research report identifies Allergan, Eisai, Novartis, and Teva Pharmaceutical Industries as the key vendors in the global dementia treatment market.

This industry research report also presents a competitive analysis of the market by drug class (MAO inhibitors, AChE inhibitors, and Glutamate inhibitors) and by geography (the Americas, APAC, and EMEA).

Market research analysts at Technavio predict that the global dementia and movement disorder treatment market will grow at a CAGR of more than 4% by 2021. This market research analysis identifies the need for disease modifying drugs (DMDs) as one of the primary growth factors for this market.

Dementia Related Associations and Societies around the Globe

  • Alzheimer’s Associations
  • Dementia Society of America, UAS
  • Foundation Alzheimer’s Aruba (FAA), Aruba
  • Alzheimer’s Australia
  • Dementia Research Foundation, Australia
  • Alzheimer’s Society
  • World Dementia Council, UK
  • Dementia Alliance International, USA
  • Society of Neuroscience, Washington, DC
  • The British neuroscience Associations, UK
  • National Institute of Health and Ageing, USA

Dementia Related Research Centers around the Globe

  • Dementia Research Centre - UCL, UK
  • Arizona Alzheimer’s Disease Centre, USA
  • Centre for Dementia - The University of Nottingham, UK
  • University of Virginia Memory and Aging Clinic, USA
  • Centre for Dementia Studies - BSMS, UK
  • The Chinese University of Hong Kong, China
  • Alzheimer Scotland Dementia Research Centre, UK
  • Clinical Research Centre For Dementia of South Korea
  • Centre for Ageing and Dementia Research, UK
  • The Dementia Association of Thailand
  • Dementia Collaborative Research Centre, Australia
  • Karolinska Institute, Sweden
  • Alzheimer's and Related disorders Society of India (ARDSI), India

Dementia Associations in Canada

  • Alzheimer Society of Canada
  • Alzheimer’s disease Neuroimaging Initiative Centers
  • Canadian Institute for Health Information
  • Canadian Institute of Health Research
  • The Toronto Dementia Research Alliance
  • Brain Canada Foundation
  • Centre for Addiction and Mental Health
  • Canadian Home Care Associations
  • Sunnybrook Health Sciences Centre
  • University Health Network
  • Clinic for Alzheimer Disease and Related Disorders
  • Dementia Friends Canada

Targeted Audience

  • Dementia Professionals
  • Dementia Caregivers
  • Dementia patients
  • Neuroscientist
  • Neurobiologist
  • Diagnostic Laboratories and Companies
  • Dementia related Associations and Societies
  • Neurophysiologist and Neuropsychologist
  • Biological Psychologist
  • Neuroscience Nurse
  • Students and delegates
  • Neuro drug Manufacturers
  • Diagnostic Laboratories and Companies
  • Dementia related Associations and Societies
  • Pharmaceutical Companies

Conclusions

Dementia is one of the biggest global public health challenges. It is a brain disorder and the treatment is no far developed completely. This conference will include all the major aspects in the field of dementia and the breakthrough in research and care.

This Dementia conference would be very profitable to all of the attendees and will bring together Scientists, researchers, medical professionals to exchange their research, ideas, concept as well as their knowledge.

References

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5232417/

http://www.who.int/mediacentre/factsheets/fs362/en/

https://www.j-alz.com/board

http://www.neurologyconference.com/2016/workshop/pre-conference-workshop-on-neurology-and-neurological-disorder

https://www.technavio.com/report/global-dementia-and-movement-disorder-treatment-market

Dementia 2019 Conference Report

The treasured conference 2nd International Conference on Dementia & Dementia Care 2019 organized by Meetings International (Meetings Int.) was held on April 15-16, 2019 at Hotel Park Inn by Radisson Toronto Airport West, 175 Derry Rd E, Mississauga, ON L5T 2Z7, Canada. The conference highlighted the theme, Breakthrough in Dementia Research and Care”. Benevolent response and active participations were received from the Editorial Board Members of Supporting Journals as well as from the Scientists, Doctors, Researchers, Students and Leaders from the fields of Dementia research, who made this event inspiringly successful.

The conference was initiated with a warm welcome note from honourable mayor and our special thanks to Bonnie Crombie, Mayor, City of Mississauga and Dawn Wiggins, New Dementians, Canada the honourable moderator for the conference who contributed a major part to the success of this event. The conference was marked by the presence of renowned scientists, talented young researchers, students and business delegates driving the two days event into the path of success with thought-provoking keynote and plenary presentations. Active participation and generous response were received from the Organizing Committee Members. Professors, Researchers, and Students from diverse groups made this conference as one of the most successful and productive events in 2019 from Meetings Int.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, poster presentations, video presentations and featured with Workshop which the following topics were highlighted as Keynote presentations:

  • Title: The neuroimmunomodulation theory in Alzheimer’s disease by Ricardo B Maccioni, University of Chile, Chile
  • Title: Diagnostic issues and the nature of the relationship between dementia
  • and depression by Donald A Davidoff, Harvard Medical School, USA
  • Title: Dementia is a disease of the ependymal layer: Novel theory from looking at cognitive impairment in multiple sclerosis by Philip A McMillan, MRCP, UK
  • Title: The Amica cognitive well-being program: Maximizing capacity for
  • residents by Heather Palmer, Amica Senior Lifestyles, Canada

The conference was well-attended with the majority of participants from USA. We also welcomed international delegates from Slovenia, Netherlands, UK, USA, Canada, Australia, Chile, Sweden and Israel.

We are glad to inform that all accepted abstracts for the conference have been published in “International Journal of Mental Health & Psychiatry” as a special issue. Our special thanks to the editors of International Journal of Mental Health & Psychiatry: Open Access and the organizing committee members, Chair and Co-Chairs for their immense support and beneficial approach.

Sessions were chaired and co-chaired by:

  • Ricardo B Maccioni, University of Chile, Chile
  • Dawn Wiggins, New Dementians, Canada

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Dementia | Dementia Care & Awareness | Alzheimer’s disease | Treatment Strategies | Neuroimaging

Dementia 2019 Conference witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of dementia and dementia care.

Contact us for more queries…!!!!

  • Dementia
  • Dementia Care & Awareness
  • Alzheimers disease
  • Neurodegenerative diseases
  • Ageing & Dementia
  • Biomarkers for Dementia
  • Diagnostic Tools & Tests for Dementia
  • Treatment Strategies & Drug Development
  • Therapeutic Approach towards Dementia
  • Clinical Trials & Study in Dementia
  • Neuroimaging
  • Recent Studies & Case reports

10 Organizing Committee Members

10 Renowned Speakers

Donald Davidoff

Harvard Medical School
USA

Bobbi Carducci

Author, Confessions of an Imperfect Caregiver
USA

Heather Palmer

Amica Mature Lifestyles
Canada

Ricardo Maccioni

University of Chile
Chile

Dawn Wiggins

Certified Dementia Practitioner
Canada

Norman Mc Namara

The Purple Angel Dementia Awareness Campaign
UK

Laurie Gunter Mantz

Dementia Training for Life
USA

Fangyu Peng

University of Texas Southwestern Medical Center
USA

Philip McMillan

Membership of the Royal Colleges of Physicians of the United Kingdom
UK

Neja Samar Brencic

IZRIIS Institute
Slovenia

Media Partners & Collaborations

  • Media Partner

  • Media Partner

  • Media Partner

  • Media Partner

  • Media Partner

  • Media Partner

  • Media Partner

  • Media Partner

  • Collaboration

  • Collaboration